Long-term outcome of Epstein–Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term outcome of Epstein–Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT

Published:2017-08-23 Issue:5 Volume:59 Page:1172-1179
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kinch Amelie¹^ORCID,Hallböök Helene²,Arvidson Johan³,Sällström Kalle¹,Bondeson Kåre⁴,Pauksens Karlis¹

Affiliation:

1. Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden;

2. Department of Medical Sciences, Section of Hematology, Uppsala University, Uppsala, Sweden;

3. Department of Women’s and Children’s Health, Section of Pediatric Oncology, Uppsala University, Uppsala, Sweden;

4. Department of Medical Sciences, Section of Clinical Virology, Uppsala University, Uppsala, Sweden

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1365860

Reference28 articles.

1. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

2. New Malignancies After Blood or Marrow Stem-Cell Transplantation in Children and Adults: Incidence and Risk Factors

3. EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning

4. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

2. Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab;Transplantation and Cellular Therapy;2024-05

3. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07

4. Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder;Current Oncology Reports;2023-05-10

5. Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder;Cancers;2022-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3